Home » Archive

News

News, Syndication »

Second annual Pedal the Cause gears up for cancer research

Posted by sandiegobiotech April 11th, 2014 .
No Comments

Pedal the Cause kick-off event 2014.

More...

News, Syndication »

Second annual Pedal the Cause gears up for cancer research

Posted by sandiegobiotech April 11th, 2014 .
No Comments

Pedal the Cause kick-off event 2014.

More...

News, Syndication »

Second annual Pedal the Cause gears up for cancer research

Posted by sandiegobiotech April 11th, 2014 .
No Comments

Pedal the Cause kick-off event 2014.

More...

News, Syndication »

Second annual Pedal the Cause gears up for cancer research

Posted by sandiegobiotech April 11th, 2014 .
No Comments

Pedal the Cause kick-off event 2014.

More...

News, Syndication »

Second annual Pedal the Cause gears up for cancer research

Posted by sandiegobiotech April 11th, 2014 .
No Comments

Pedal the Cause kick-off event 2014.

More...

News, Syndication »

Tech and Biotech Stocks Slump

Posted by sandiegobiotech April 10th, 2014 .
No Comments

Biotech and tech stocks have been in a slump for the past three weeks, evidenced in part by the 3.1 percent drop in the Nasdaq Composite — the worst one day percentage decline, according to MarketWatch, since November 2011.

More...

News, Syndication, UCSD News »

Campus Volunteers Help Welcome More than 20,000 Admitted Students and Families to Triton Day

Posted by sandiegobiotech April 10th, 2014 .
No Comments

Hundreds of volunteers arrived on campus Saturday to welcome newly admitted freshmen to UC San Diego for Triton Day. Now in its third year, Triton Day is an annual event designed to inspire admitted freshmen to see themselves as …

More...

News, Syndication, UCSD News »

New Venture Capital Fund to Commercialize Innovations from UC San Diego Community

Posted by sandiegobiotech April 10th, 2014 .
No Comments

A group of UC San Diego alumni have created a venture capital fund—the Triton Technology Fund—that is specifically focused on commercializing innovations by UC San Diego faculty, students and alumni. The fund will offer an additional option for UC San Diego innovators looking for the investment and expertise that is often crucial for successful technology commercialization.

More...

News, Syndication »

Celladon Gets FDA’s “Breakthrough Therapy” Status for Gene Therapy

Posted by sandiegobiotech April 10th, 2014 .
No Comments

[Corrected 4/10/14, 12:25 pm. See below.] The FDA has granted its “breakthrough therapy” designation for a gene therapy treatment in mid-stage development by San Diego’s Celladon (NASDAQ: CLDN), for…

[[Click headline to continue reading.]]

More...

News, Syndication »

Jury tells NuVasive to pay $30 million

Posted by sandiegobiotech April 9th, 2014 .
No Comments

San Diego medical device company says it will fight trademark infringement verdict.

More...